INLIF LIMITED reports news on its industrial automation business, including the research, development, manufacturing, and sale of injection molding machine-dedicated manipulator arms. Through its operating subsidiary Ewatt Robot Equipment Co., Ltd., the company also discusses automation and testing equipment for the new energy sector, including applications along the lithium battery and energy storage value chain.
Recurring INLF updates include financial results, customer and market demand for automation equipment, R&D and product expansion, construction of its robotics digital intelligent manufacturing base, Nasdaq listing compliance, and capital-structure actions involving its Class A and Class B ordinary shares.
INLIF (Nasdaq: INLF) received a Nasdaq deficiency letter dated October 27, 2025, notifying the company it failed to meet the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) based on closing bids from September 11, 2025 through October 24, 2025.
The Notice does not have an immediate delisting effect and grants a 180-calendar-day compliance period until April 27, 2026. The company can regain compliance by achieving a closing bid ≥ $1.00 for 10 consecutive business days, or may seek an additional 180 days if it meets Nasdaq market value and other initial listing standards and notifies Nasdaq of intent to cure, which could include a reverse stock split.
INLIF (Nasdaq: INLF) announced on October 23, 2025 a strategic expansion into the new energy sector through its operating subsidiary Ewatt Robot Equipment Co., Ltd., shifting from injection-molding manipulator arms toward turnkey automation for lithium battery and energy storage manufacturing.
Key commercialized products include a Cell Outer Blue Film Dispensing System (up to 24 PPM, first-pass yield >99%), Module Bonding & Dispensing Equipment (±1% dispensing accuracy, 88s cycle time, 2,600ml glue barrel), and an automated production line covering cell loading through EOL testing. The company said it is expanding R&D, engineering, and supply-chain talent to support commercialization and long-term growth.
INLIF (NASDAQ:INLF), a manufacturer of injection molding machine manipulator arms, reported its H1 FY2025 financial results. The company achieved revenue of $10.27 million, up 52.49% year-over-year, driven by strong demand from new energy vehicles, home appliances, and packaging industries. However, despite revenue growth, INLIF reported a net loss of $1.98 million compared to a net income of $0.39 million in the prior year period.
The company's gross profit increased 4.90% to $1.80 million, though gross margin declined to 17.50% from 25.45%. Operating expenses surged 148.04% to $3.87 million, primarily due to increased administrative costs and share-based compensation. INLIF's strategic initiatives included participation in industry exhibitions, generating over 450 qualified leads and 15 new orders, while expanding its R&D team from 141 to 186 employees.
INLIF, a manufacturer of injection molding machine manipulator arms, reported strong financial results for fiscal year 2024. The company achieved a 25.26% revenue increase to $15.80 million, while net income grew 18.78% to $1.61 million compared to 2023.
Key financial highlights include:
- Gross profit increased 9.49% to $4.55 million
- Earnings per share rose to $0.13 from $0.11
- Cash and equivalents reached $2.47 million
The company's growth was driven by increased sales across multiple segments, with raw materials and scraps sales showing the highest growth at 136.61%. INLIF completed its IPO on January 3, 2025, offering 2 million shares at $4.00 per share on Nasdaq. Despite higher revenues, gross margin declined to 28.83% from 32.98%. The company is expanding its market presence through exhibitions in China and exploring opportunities in Southeast Asia and India.
INLIF (Nasdaq: INLF), a manufacturer of injection molding machine-dedicated manipulator arms, has completed its initial public offering of 2,000,000 ordinary shares at US$4.00 per share, raising US$8 million in gross proceeds. The shares began trading on the Nasdaq Capital Market on January 2, 2025.
The company granted underwriters a 45-day option to purchase up to 300,000 additional shares. The net proceeds will fund: construction of a 5G digital intelligent equipment production base, establishment of 24 local marketing and service offices in China, construction of an industrial robot and automation application technology R&D center, and working capital.
AC Sunshine Securities served as the underwriter for this firm commitment offering, which was declared effective by the SEC on December 20, 2024.
INLIF , a manufacturer of injection molding machine-dedicated manipulator arms, has announced the pricing of its initial public offering (IPO) of 2,000,000 ordinary shares at $4.00 per share. The company expects to raise $8 million in gross proceeds and will begin trading on the Nasdaq Capital Market under the symbol 'INLF' on January 2, 2025.
The underwriters have a 45-day option to purchase an additional 300,000 shares. Proceeds will fund the construction of a 5G digital intelligent equipment production base, establishment of 24 local marketing offices in China, construction of a research center, and working capital. The offering is expected to close around January 3, 2025, with AC Sunshine Securities acting as underwriter.